The following story originally appeared in the Aug. 24, 2017, edition of the VUMC Reporter.  For patients with a common type of epilepsy known as temporal lobe epilepsy (TLE), the only treatment choices are anti-seizure drugs or surgery to remove the focus of the seizures in part of the brain known as the hippocampus.

The Department of Radiology and Radiological Sciences recently welcomed faculty with secondary appointments from Vanderbilt University Medical Center (VUMC) and Vanderbilt University departments of Anesthesiology and Biomedical Engineering (BME).

The Department of Radiology recently named David Pickens, Ph.D., Associate Professor of Radiology and Radiological Sciences, as the Chief of the Section of Radiological Sciences. Dr. Pickens assumes his new role following the retirement of former section chief, professor emeritus Ronald Price, Ph.D., earlier this year.

The Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) Journal of Nuclear Medicine (JNM) recently shared a press release announcing an increase in its 2016 impact factor and its rank among the industry’s top medic

Ryan Muller, M.D., Assistant Professor of Radiology and Radiological Sciences, was recently appointed Associate Program Director for the Interventional Radiology Residency program.

Department of Radiology and Radiological Sciences 15th Annual Pendergrass Grand Rounds Lecture in Thoracic Radiology "Establishing a Medical Startup"

Department of Radiology and Radiological Sciences Grand Rounds "Leadership and Crisis Management"

The Department of Radiology last week hosted its annual recognition ceremony for graduating residents and fellows. More than 140 people attended the ceremony, held at the University Club of Nashville, to celebrate the eight residents and 13 fellows who complete training in their respective programs at the end of this month.

The following story originally appeared in the June 14, 2017, edition of the VUMC Reporter.    About 10 percent of patients with colorectal cancer express a mutated form of the signaling molecule BRAF, which may be targeted for treatment by selective BRAF inhibitors. PET (positron emission tomography) imaging using a standard glucose probe is not able to predict response to BRAF inhibitors.